Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.0 | 0.0 | 3.0 |
| Revenue growth | | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 6.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | -3.0 |
| Gross margin | | | | -100.0% |
| Research and development | 4.3 | 3.0 | 2.4 | |
| General and administrative | 5.6 | 2.6 | 0.8 | 0.9 |
| EBIT | -10.0 | -5.7 | -3.2 | -3.9 |
| EBIT margin | | | | -130.0% |
| Pre-tax income | -9.9 | -6.3 | -3.8 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | |
| Net income | -9.9 | -6.3 | -3.8 | 0.0 |
| Net margin | | | | 0.0% |
| |
| Diluted EPS | ($1.09) | ($1.21) | ($1.72) | $0.00 |
| Shares outstanding (diluted) | 9.1 | 5.2 | 2.2 | 2.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|